Beihai Gofar Chuanshan Biological Co., Ltd. (SHA:600538)

China flag China · Delayed Price · Currency is CNY
5.60
+0.01 (0.18%)
Jul 15, 2025, 9:39 AM CST
37.93%
Market Cap 2.93B
Revenue (ttm) 331.51M
Net Income (ttm) -78.35M
Shares Out 524.20M
EPS (ttm) -0.18
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 953,800
Average Volume 9,114,949
Open 5.56
Previous Close 5.59
Day's Range 5.55 - 5.62
52-Week Range 2.90 - 6.40
Beta 0.10
RSI 49.21
Earnings Date Aug 22, 2025

About SHA:600538

Beihai Gofar Chuanshan Biological Co., Ltd. engages in the production and distribution of pharmaceutical products in China. The company offers various medicines and medical devices; and produces and sells pearl eye drops, pearl powder, nacre powder, weichangning granules, and forensic identification technical services, etc. It is also involved in providing DNA testing equipment; sells consumables and testing services; and art sales. The company was formerly known as Beihai Gofar Marine Biological Industry Co., Ltd. and changed its name to Beiha... [Read more]

Sector Materials
Founded 1993
Employees 453
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 600538
Full Company Profile

Financial Performance

In 2024, SHA:600538's revenue was 340.47 million, a decrease of -7.77% compared to the previous year's 369.15 million. Losses were -93.85 million, 14.0% more than in 2023.

Financial Statements

News

There is no news available yet.